Nasdaq-listed Windtree Therapeutics unveils new funding plans to generate $520 million. Most of the funds will be used to accelerate the firm’s BNB treasury strategy. According to a recent press release, the Nasdaq-listed biotechnology company announced that it has signed…
Related Posts
New class action hearing scheduled against Ripple
A new hearing in the class action lawsuit filed against Ripple Labs referred to as Zakinov v. Ripple,…
Marathon CEO expects no explosive surge for Bitcoin, halving priced in
Marathon CEO Fred Thiel suggests that Bitcoin’s upcoming halving may already be partially priced in due to the…
Experts place big bets on Lightchain AI as the next market changer
Lightchain AI raises $10.4 million in presale, positioning itself as a blockchain changer with unique tech and market…